Vivakor to structure acquisition partners to commercialize VivaSlices and VivaSight technologies

Vivakor, Inc. (OTCBB:VIVK) today announced that due to the increased interest in the Company's technologies, the Company is looking to structure acquisition partners for its technologies which will allow for the investment needed to fully commercialize VivaSlices and VivaSight technologies.

As our Digital Photo Refractor research grant has completed, the market indications and applications of our technology have expanded.  Not only has the demand for our vision screening technology expanded to potentially include all ages, the demand for international vision screening has opened potential distribution outlets for VivaSight products that the Company is striving to take to market through its fund raising efforts.

VivaSlices, MRI enhancement software, continues to make strides as the company seeks financing to ensure the technology will be ready for new regulations that take effect next year.  The Company has sought out commercialization and finance partners for VivaSlices technology and looks forward to completing such efforts.

Management feels that the current stock price and company market capitalization is undervalued and the outlook for current product sales and pre-orders for VivaSight and VivaSlices technologies surpass current market values.  As financing objectives are completed, management believes the fundamentals of the Company will insure Vivakor's long term strategy of extending the length and quality of life through detection and prevention.